CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VKTX — Viking Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,964,571
-$671,807 QoQ
Shares Held
736,465
+5.2% QoQ
Ownership
0.634%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99972843244419.ToString("F0")%
Shared 0.ToString("F0")%
None 0.00027156755582410566.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. VKTX ranks #51 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in VKTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,964,571 | 736,465 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,636,378 | 700,295 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,335,766 | 697,708 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,276,630 | 727,420 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,192,312 | 711,897 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $29,320,956 | 728,652 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $45,304,446 | 715,597 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $35,594,889 | 671,475 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $68,796,688 | 838,984 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,435,758 | 775,699 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,472,092 | 765,320 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,210,417 | 259,742 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $610,522 | 36,668 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $272,280 | 28,966 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $78,787 | 28,966 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $128,506 | 44,466 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $589,230 | 196,410 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $815,699 | 177,326 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,080,756 | 172,095 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,027,518 | 171,539 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,052,827 | 166,455 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $873,117 | 155,083 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $904,119 | 155,347 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,164,256 | 161,478 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $786,956 | 168,153 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||